Zag Bio is targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
11/03/25	$80,000,000	Series A	Polaris Partners T1D Exchange	undisclosed